| Meta-regulation and nanotechnologies: the challenge of responsibilisation within the European Commission’s code of conduct for responsible nanosciences and nanotechnologies … B Dorbeck-Jung, C Shelley-Egan Nanoethics 7 (1), 55-68, 2013 | 76 | 2013 |
| The association between socioeconomic status and pandemic influenza: Systematic review and meta-analysis SE Mamelund, C Shelley-Egan, O Rogeberg PLoS One 16 (9), e0244346, 2021 | 75 | 2021 |
| Translation, transduction, and transformation: expanding practices of responsibility across borders T Doezema, D Ludwig, P Macnaghten, C Shelley-Egan, EM Forsberg Journal of Responsible Innovation 6 (3), 323-331, 2019 | 65 | 2019 |
| The association between socioeconomic status and pandemic influenza: protocol for a systematic review and meta-analysis SE Mamelund, C Shelley-Egan, O Rogeberg Systematic reviews 8, 1-6, 2019 | 51 | 2019 |
| Joint declaration on mainstreaming RRI across Horizon Europe A Gerber, EM Forsberg, C Shelley-Egan, R Arias, S Daimer, G Dalton, ... Journal of Responsible Innovation 7 (3), 708-711, 2020 | 50 | 2020 |
| Implementing Responsible Research and Innovation in Research Funding and Research Conducting Organisations—What Have We Learned so Far? F Ferri, N Dwyer, S Raicevich, P Grifoni, H Altiok, HT Andersen, Y Laouris, ... Governance and Sustainability of Responsible Research and Innovation …, 2018 | 49 | 2018 |
| Devices of responsibility: Over a decade of responsible research and innovation initiatives for nanotechnologies C Shelley-Egan, DM Bowman, DKR Robinson Science and Engineering Ethics 24, 1719-1746, 2018 | 46 | 2018 |
| Positions and responsibilities in the ‘real’world of nanotechnology A Rip, C Shelley-Egan Nanotechnology and Its Governance, 101-107, 2019 | 45 | 2019 |
| Consolidating RRI and Open Science: understanding the potential for transformative change C Shelley-Egan, MD Gjefsen, R Nydal Life Sciences, Society and Policy 16 (1), 7, 2020 | 37 | 2020 |
| Ethics in practice: responding to an evolving problematic situation of nanotechnology in society. C Shelley-Egan | 35* | 2011 |
| The ambivalence of promising technology C Shelley-Egan Nanoethics 4, 183-189, 2010 | 32 | 2010 |
| Testing the obligations of presence in academia in the COVID-19 era C Shelley-Egan Sustainability 12 (16), 6350, 2020 | 25 | 2020 |
| Nano‐Industry Operationalizations of “Responsibility”: Charting Diversity in the Enactment of Responsibility C Shelley‐Egan, SR Davies Review of policy research 30 (5), 588-604, 2013 | 21 | 2013 |
| RRI Futures: learning from a diversity of voices and visions M Van Oudheusden, C Shelley-Egan Journal of Responsible Innovation 8 (2), 139-147, 2021 | 19 | 2021 |
| A game with rules in the making–how the high probability of waiting games in nanomedicine is being mitigated through distributed regulation and responsible innovation J d'Silva, DKR Robinson, C Shelley-Egan Technology Analysis & Strategic Management 24 (6), 583-602, 2012 | 19 | 2012 |
| Evaluating Ethical Frameworks for the Assessment of Human Cognitive Enhancement Applications EM Forsberg, C Shelley-Egan, E Thorstensen, L Landeweerd, B Hofmann Springer, 2017 | 17 | 2017 |
| Ethical Assessment of Research and Innovation: A Comparative Analysis of Practices and Institutions in the EU and selected other countries. C Shelley-Egan, P Brey, R Rodrigues, D Douglas, A Gurzawska, L Bitsch, ... European Commission, 2015 | 17 | 2015 |
| The challenge of distributing regulatory responsibilities for unknown risks:'Nano'-cosmetics and the EU cosmetics regulation as a case study C Shelley-Egan, DM Bowman Journal of Clinical Research & Bioethics 6 (2), 1, 2015 | 17 | 2015 |
| Responsible Research and Innovation in the context of human cognitive enhancement: some essential features C Shelley-Egan, AB Hanssen, L Landeweerd, B Hofmann Journal of Responsible Innovation 5 (1), 65-85, 2018 | 16 | 2018 |
| RRI-Practice Policy Recommendations and Roadmaps, RRI-Practice project report. Deliverable 16.2 R Owen, EM Forsberg, C Shelley-Egan | 15 | 2019 |
